Drug Safety Newsletter – Edition 114 – 21 December 2023
21/12/2023
Medicines for human use
Safety update
The latest edition of the HPRA Drug Safety Newsletter (edition 114) includes important updates to support the safe and appropriate use of the following medicines:
Montelukast: New boxed warning to raise further awareness of the risk of neuropsychiatric events.
Paracetamol: Monitoring risk factors for hepatotoxicity in patients during treatment
Ustekinumab: New warning regarding lupus-related conditions and updated advice regarding infections
Venlafaxine: Updated warning and advice on complex cases involving overdose and severe poisoning